Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

Both Headspace and Silvercloud – mobile apps for mental health – are associated with significant improvements in depression and anxiety.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes. (HealthDay News) — For patients with type 2 diabetes, sodium-glucose cotransporter ...

Trial follow-up data showed no improvement in kidney failure and death risks among blood pressure-lowering strategies for patients with ADPKD.

A new CISA portal includes the ability to save and update reports and share submitted reports with colleagues or clients for third-party reporting.

Darolutamide plus androgen deprivation therapy (ADT), without docetaxel, significantly prolonged radiographic progression-free survival compared with placebo plus ADT in patients with metastatic ...

Ocular manifestations are common among patients with all types of antineutrophil cytoplasmic antibody-associated vasculitis, and machine learning-based predictive models offer potential for early ...

In patients with kidney cancer undergoing surgery, the risk for kidney failure (ESRD) appears no lower with partial kidney removal (nephrectomy).

Most common SPM subtypes were hematologic malignancies followed by solid tumors, nonmelanoma skin cancers. (HealthDay News) — The overall second primary malignancy (SPM) point estimate was 5.8% ...

Elevated interleukin-6 levels were linked to an increased risk for obesity-related cancers among patients with newly diagnosed type 2 diabetes. Elevated interleukin-6 (IL-6) levels are associated ...